Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Erythropoiesis

Erythropoiesis

Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...

Lineage Commitment

Lineage Commitment

Commitment is the process whereby stem cells:

Somatic to iPS Cell Reprogramming

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...

Methods of Nuclear Reprogramming

Methods of Nuclear Reprogramming

Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for injury repair.

Introduction to Nuclear Reprogramming

Introduction to Nuclear Reprogramming

Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...

Hematopoiesis

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

WDR5 serves in co-activation and influences genome targeting of KLF3.

Nucleic acids research·2025

Same author

Removal of promoter CpG methylation by epigenome editing reverses HBG silencing.

Nature communications·2025

Same author

Hydroxyurea reduces the levels of the fetal <i>globin</i> gene repressors ZBTB7A/LRF and BCL11A in erythroid cells <i>in vitro</i>.

Journal of sickle cell disease·2025

Same author

The glucocorticoid receptor elicited proliferative response in human erythropoiesis is BCL11A-dependent.

Stem cells (Dayton, Ohio)·2024

Same author

The glucocorticoid receptor elicited proliferative response in human erythropoiesis is BCL11A-dependent.

bioRxiv : the preprint server for biology·2024

Same author

Base editing of key residues in the BCL11A-XL-specific zinc finger domains derepresses fetal globin expression.

Molecular therapy : the journal of the American Society of Gene Therapy·2024

Same journal

Integrative Meta-Analysis and WGCNA Reveal Candidate Diagnostic Hub Genes in Clear Cell Carcinoma.

International journal of cell biology·2026

Same journal

Important Aspects of siRNA Design for Optimal Efficacy In Vitro and In Vivo.

International journal of cell biology·2026

Same journal

Preservative Effectiveness of Lactic Acid Bacteria on Fruits and Vegetables.

International journal of cell biology·2025

Same journal

Radioprotective Effects of Vitamin C, Cimetidine, and Famotidine on Lipid Peroxidase and Hepatic Glutathione Levels in Mouse Liver.

International journal of cell biology·2025

Same journal

A Comparative Study on the Effects of Mesenchymal Stem Cells and Their Conditioned Medium on Caco-2 Cells as an In Vitro Model for Inflammatory Bowel Disease.

International journal of cell biology·2024

Same journal

The Effect of Exposure to Mobile Phones on Electrical Cardiac Measurements: A Multivariate Analysis and a Variable Selection Algorithm to Detect the Relationship With Mean Changes.

International journal of cell biology·2024

See all related articles

Search research articles

Related Experiment Video

Updated: May 30, 2026

Direct Lineage Reprogramming of Adult Mouse Fibroblast to Erythroid Progenitors

Direct Lineage Reprogramming of Adult Mouse Fibroblast to Erythroid Progenitors

Published on: December 14, 2018

Cellular Reprogramming toward the Erythroid Lineage.

Laura J Norton¹, Alister P W Funnell, Richard C M Pearson

¹School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW 2052, Australia.

International Journal of Cell Biology

|August 4, 2011

Summary

This summary is machine-generated.

Cellular reprogramming offers a novel approach to treating haemoglobinopathies like thalassaemia and sickle cell disease. This innovative method shows promise for generating functional erythrocytes, potentially overcoming limitations of current therapies.

More Related Videos

Lentiviral-mediated Knockdown During Ex Vivo Erythropoiesis of Human Hematopoietic Stem Cells

Lentiviral-mediated Knockdown During Ex Vivo Erythropoiesis of Human Hematopoietic Stem Cells

Published on: July 16, 2011

Reprogramming Mouse Embryonic Fibroblasts with Transcription Factors to Induce a Hemogenic Program

Reprogramming Mouse Embryonic Fibroblasts with Transcription Factors to Induce a Hemogenic Program

Published on: December 16, 2016

Related Experiment Videos

Last Updated: May 30, 2026

Direct Lineage Reprogramming of Adult Mouse Fibroblast to Erythroid Progenitors

Direct Lineage Reprogramming of Adult Mouse Fibroblast to Erythroid Progenitors

Published on: December 14, 2018

Lentiviral-mediated Knockdown During Ex Vivo Erythropoiesis of Human Hematopoietic Stem Cells

Lentiviral-mediated Knockdown During Ex Vivo Erythropoiesis of Human Hematopoietic Stem Cells

Published on: July 16, 2011

Reprogramming Mouse Embryonic Fibroblasts with Transcription Factors to Induce a Hemogenic Program

Reprogramming Mouse Embryonic Fibroblasts with Transcription Factors to Induce a Hemogenic Program

Published on: December 16, 2016

Area of Science:

Biomedical Science
Regenerative Medicine
Hematology

Background:

Haemoglobinopathies, including thalassaemia and sickle cell disease, represent a significant global health challenge.
Current treatments like blood transfusions and fetal haemoglobin induction have limitations and risks, including transfusion dependence, infections, and iron overload.

Purpose of the Study:

To explore the potential of cellular reprogramming as a therapeutic strategy for haemoglobinopathies.
To discuss the recent advancements in producing erythrocytes through cellular reprogramming.

Main Methods:

Review of current literature on cellular reprogramming techniques.
Analysis of the successful in-vitro production of erythrocytes.

Main Results:

Significant advancements in cellular reprogramming have enabled the generation of erythrocytes in culture.
This breakthrough opens new avenues for therapeutic development.

Conclusions:

Cellular reprogramming holds considerable promise for developing novel treatments for haemoglobinopathies.
This approach may offer an alternative to existing therapies, potentially reducing associated risks and burdens.